Titlebook: Head and Neck Cancer; Brockstein Bruce,Masters Gregory Book 2003 Springer Science+Business Media New York 2003 Staging.cancer.carcinoma.ce

調(diào)戲

書(shū)目名稱Head and Neck Cancer影響因子(影響力)




書(shū)目名稱Head and Neck Cancer影響因子(影響力)學(xué)科排名




書(shū)目名稱Head and Neck Cancer網(wǎng)絡(luò)公開(kāi)度




書(shū)目名稱Head and Neck Cancer網(wǎng)絡(luò)公開(kāi)度學(xué)科排名




書(shū)目名稱Head and Neck Cancer被引頻次




書(shū)目名稱Head and Neck Cancer被引頻次學(xué)科排名




書(shū)目名稱Head and Neck Cancer年度引用




書(shū)目名稱Head and Neck Cancer年度引用學(xué)科排名




書(shū)目名稱Head and Neck Cancer讀者反饋




書(shū)目名稱Head and Neck Cancer讀者反饋學(xué)科排名

巧思

物種起源

客觀

circumvent

Treatment of Metastatic Head and Neck Cancer: Chemotherapy and Novel Agents, we will begin to cure these patients who currently have a life expectancy of 6–9 months. Palliation will remain the intent of therapy in the recurrent setting and for this reason it is paramount that we focus on these effects in our research.

armistice

Book 2003options for patient types or specific patients easily. Considerations of supportive care, late toxicities and quality of life, often overlooked are reviewed in detail. ..This is a comprehensive summary of the current state of the art research and treatment. .

使混合

0927-3042 dards and options for patient types or specific patients easily. Considerations of supportive care, late toxicities and quality of life, often overlooked are reviewed in detail. ..This is a comprehensive summary of the current state of the art research and treatment. .978-1-4419-5332-2978-0-306-48060-7Series ISSN 0927-3042 Series E-ISSN 2509-8497

細(xì)菌等

Harry Staffileno Jr. DDS, MS,Leslie Reeder DDSliver transplantation in patients with alcoholic liver disease are also discussed. We provide a list of ongoing clinical trials and identify novel targets and approaches that may deserve investigation in alcoholic liver disease based on evidence from preclinical studies or state-of-the-art pathomechanistic understanding.

Cupidity

New Therapies for Locoregionally Advanced and Locoregionally Recurrent Head and Neck Cancer,n with currently available treatment options. The availability of these new therapeutic regimens may expand the options of patients with recurrent disease and hopefully will help improve the outcome in a group of patients who otherwise have little prospect of attaining cure.

灌輸

Oral, Dental, and Supportive Care in the Cancer Patient, of the diagnosis(es). Therapeutic management is generated by the diagnosis (Table 2). The oral and dental care management should be individualized on a case by case basis as there are so many variables involved with the cancer patient.